This session will explore the challenges and opportunities scientists, research administrators, and funders face in navigating misinformation within today’s information ecosystem. With a focus on rare disease research, the... read more →
This 60-minute session will feature lightning talks followed by an interactive panel discussion focused on sustaining the research pipeline by strengthening support for early- and mid-career investigators. Speakers will... read more →
Non-profit research funders are seeing unprecedented growth in grant submissions as needs of the research community rise and federal funding landscapes and priorities shift. This session will explore practical... read more →
Bring your research grant evaluation questions to this interactive, peer-driven clinic! In a supportive open-mic format, participants will have 5 minutes to present a real-world evaluation challenge they’re facing.... read more →
This professional development workshop will help members understand the full landscape of information threats facing biomedical research today — from AI-generated false content to misrepresented findings — and... read more →
Patient registries and clinical data repositories are only as powerful as the data standards they leverage. Nicole Harmon, Chief Operating Officer at the Clinical Data Interchange Standards Consortium (CDISC)... read more →
This session will showcase concrete, case-based examples of how funders and research organizations meaningfully engage patients in research funding and other core initiatives, such as including patient advocates in... read more →
This initial session introduced HRA members to our sponsoring host, the American Society of Clinical Oncology (ASCO), Conquer Cancer, and our funding sponsors, the Alzheimer’s Association, BrightFocus Foundation, Burroughs Wellcome Fund, and... read more →
As the Fall HRA Members Meeting comes to a close, this open mic session invites attendees to reflect on the insights, strategies, and challenges discussed over the past... read more →
Federal policy decisions shape the landscape of biomedical research and profoundly influence the careers, stability, and diversity of the scientific workforce. Ongoing shifts are particularly consequential for early career... read more →